Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 219941
Company: DEVA HOLDING AS
Company: DEVA HOLDING AS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | No |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/01/2026 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
MIRABEGRON
TABLET, EXTENDED RELEASE;ORAL; 25MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 215948 | ALKEM LABS LTD |
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 219941 | DEVA HOLDING AS |
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 209485 | LUPIN |
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 218543 | MSN |
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 217989 | QILU |
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 209488 | ZYDUS PHARMS |
| MYRBETRIQ | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 202611 | APGDI |
TABLET, EXTENDED RELEASE;ORAL; 50MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 215948 | ALKEM LABS LTD |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 219941 | DEVA HOLDING AS |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 209485 | LUPIN |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 218543 | MSN |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 217989 | QILU |
| MIRABEGRON | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 209488 | ZYDUS PHARMS |
| MYRBETRIQ | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 202611 | APGDI |